Presentation TCT 2017 PLLA-Based Biolimus A9 Elution I: Outcomes With the BioMatrix Family of DES Presenter: Ioannis Iakovou, Gert Richardt, Christophe Dubois October 30, 2017
Presentation TCT 2017 The Orsiro Sirolimus-eluting Stent: Outcomes From the BIOFLOW and BIORESORT Trials Presenter: Ioannis Iakovou, Gert Richardt, Clemens von Birgelen October 30, 2017
Presentation TCT 2017 MiStent and DESSOLVE III Outcomes: Are the Stent and Clinical Trial Results Unique? Presenter: Ioannis Iakovou, Gert Richardt, Robert J. de Winter October 30, 2017
Presentation TCT 2017 Will Atherectomy Improve the Results of Drug Coated Balloons? Preclinical and Early Clinical Data Presenter: Lawrence A. Garcia, Mehdi H. Shishehbor October 30, 2017
Presentation TCT 2017 Topic 4: At the Cusp of Diminishing Returns for CV Therapies - Personalized Approaches and New Frontiers Presenter: Robert A. Byrne, Gregg W. Stone, Robert A. Harrington October 30, 2017
Presentation TCT 2017 Expanding Clinical Evidence With SYNERGY: From EVOLVE II to Real-world Registries and EVOLVE DAPT Presenter: Ioannis Iakovou, Gert Richardt, Dean J. Kereiakes October 30, 2017
Presentation TCT 2017 Pros and Cons of Bioabsorbable Polymer-Based DES: Will They Translate Into Improved Clinical Outcomes Compared to the Best Durable Polymer-Based DES? Presenter: Ioannis Iakovou, Gert Richardt, Renu Virmani October 30, 2017
Presentation TCT 2017 Topic 3: Chronic Total Occlusion PCI - What Level of Evidence Is Required for Widespread Acceptance: Hard Endpoints vs QOL Measures Presenter: Robert A. Byrne, Gregg W. Stone, J. Aaron Grantham October 30, 2017
Presentation TCT 2017 Controversial Position Statement: Polymer-Free DES Provide the Optimal Balance of Safety and Efficacy (and Will Improve Most in the Future)! Presenter: Giulio G. Stefanini, Stephan Windecker, Philip M. Urban October 30, 2017
Presentation TCT 2017 Metallic DES Are Different! How I Choose Stent Type to Match the Lesion and Patient (From 30 Years of Experience) Presenter: Giulio G. Stefanini, Stephan Windecker, Antonio Colombo October 30, 2017
Presentation TCT 2017 Are All Contemporary DES Comparable? Lessons From the SCAAR Registry Presenter: Giulio G. Stefanini, Stephan Windecker, Stefan K. James October 30, 2017
Presentation TCT 2017 Debate: DAPT Duration With Contemporary DES: Short (<1 Year) DAPT for Most ACS Patients! Presenter: John A. Bittl, Freek W.A. Verheugt, Marco Valgimigli October 30, 2017
Presentation TCT 2017 Topic 2: Outcomes Without a Clear Mechanism (Radial Mortality Benefit, Aspirin/Ticagrelor Interaction, and More) Presenter: Robert A. Byrne, Gregg W. Stone, Robert A. Harrington October 30, 2017
Presentation TCT 2017 Perspectives on Current Trials in Renal Denervation: Evolution of Design, Endpoints, and Objectives Presenter: Michael Böhm, Thomas F. Luscher, Felix Mahfoud October 30, 2017
Presentation TCT 2017 Are All Contemporary DES Comparable? Lessons From the COMPARE Trials Presenter: Giulio G. Stefanini, Stephan Windecker, Elvin Kedhi October 30, 2017
Presentation TCT 2017 BioNIR: Specifications and BIONICS/NIREUS Results in Perspective Presenter: Stephen G. Ellis, David E. Kandzari October 30, 2017
Presentation TCT 2017 Debate: DAPT Duration With Contemporary DES: Prolonged (>1 Year) DAPT for Most ACS Patients! Presenter: John A. Bittl, Freek W.A. Verheugt, Robert W. Yeh October 30, 2017
Presentation TCT 2017 Are All Contemporary DES Comparable? Lessons From the TWENTE Trials Presenter: Giulio G. Stefanini, Stephan Windecker, Clemens von Birgelen October 30, 2017
Presentation TCT 2017 POT vs Kissing Balloon Inflations: Alternatives or Complementary? Presenter: Terje K. Steigen, Leif Thuesen, Bernard R. Chevalier October 30, 2017
Presentation TCT 2017 Resolute and Onyx Zotarolimus-Eluting Stents: Device Iterations and Randomized/Registry Outcomes Data in Perspective Presenter: Stephen G. Ellis, David E. Kandzari, Matthew J. Price October 30, 2017